Indian Journal of Pharmacy and Pharmacology (IJPP) is an open-access, peer-reviewed pharmacy and pharmacology journal, published quarterly, as print and online by the Innovative Education and Scientific Research Foundation (IESRF) since 2014. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional membership, and conducting conferences, seminars, and award programs.

With the aim of faster and better dissemination of knowledge, we will be publishing articles ‘Ahead of Print’ immediately upon acceptance of manuscript. In addition, the journal allows free access (Open Access) to its contents, which is likely to attract more readers and citations to articles published in journal.

Manuscripts should be prepared in accordance with the author guidelines of the journal, which follow the recommendations of the International Committee of Medical Journal Editors (ICMJE), last updated in December 2019. Before submitting a manuscript, contributors are requested to check the guidelines, which are available on the journal website or directly from the manuscript submission website of the Manuscript Peer-Review Process (MPRP).

Aims and Scope

The primary aim of the Journal is to publish significant research that advances all aspects of drug discovery, development, and therapeutic application. The journal's comprehensive scope invites original research articles, in-depth reviews, and clinical trial studies in disciplines including Pharmacology, Pharmaceutics, Drug Delivery, Pharmaceutical Chemistry, and Pharmacognosy. The journal particularly aims to the clinical applications of natural products, mechanistic studies on drug action, and advanced biological therapies such as gene therapy, vaccines, and therapeutic proteins. The journal covers all major therapeutic areas, from cardiovascular and central nervous system disorders to oncology and infectious diseases, making it a vital resource for its diverse audience of pharmaceutical scientists, pharmacologists, clinicians, and regulatory professionals.

Indexing and Abstracting Information

Index Copernicus, Google Scholar, J- gate, ROAD, CrossRef, Microsoft Academic, Scilit, CAS Source Index.

Journal Ethics

Journal is committed to upholding the highest standards of ethical behaviour at all stages of publication. We strictly adhere to the industry associations such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE), and World Association of Medical Editors (WAME), which set standards and provide guidelines for best practices to meet these requirements. Please visit the author guidelines to know more about specific policies regarding duplicate publication, conflicts of interest, patient consent, etc.

Open Access (OA) Publication

The journal encourages open-access publishing, providing free, unrestricted online access to research outputs such as journals, articles, and books. This policy ensures rapid access to the latest research content for researchers, students, readers, scholars, and laypeople. Please visit our open-access journals for more details and information.

Creative Commons Licensing

The journal is an open-access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License (CC BY-NC-SA 4.0). This license permits non-commercial remixing, tweaking, and building upon a work, provided proper credit is given and new creations are licensed under identical terms. It also allows authors to grant certain permissions to others while retaining certain rights for themselves.

Repository Policy

Authors can publish their articles in any repository, and submitting content online can enhance citations and productive conversations, promoting accessibility and reproducibility of research findings.

Copyright of the published material

The journal takes a signed copy of the consent declaration form authors where they sign and accepts responsibility for releasing this material to the publisher on behalf of any and all co-authors. But author retains the copyright of the content and transfers all the licensing and publishing rights to the publisher. The author grants the publisher the only right to commercially utilize the article. For the duration of the copyright's full legal term, they provide the publisher, exclusive right, and license to publish. This transfer of publication rights covers the non-exclusive right to reproduction and distribute the article, including reprints, translations, photographic, reproductions, microform, electronic form (offline, online) or any other reproduction of similar nature.

Plagiarism

The journal considers plagiarism a serious breach of publication ethics. Plagiarism is defined as the act of presenting another's work, ideas, or words as one's own without proper attribution. The journal also strictly prohibits self-plagiarism, which is the redundant reuse of significant portions of an author's own previously published work without appropriate citation. Self-plagiarism involves reusing one’s own work without proper citation, using another's production without credit, or presenting a new idea derived from an existing source. Our Journal considers this as plagiarism, and iThenticate software is provided to editors and reviewers.

AI Guidelines

Human judgment is crucial in learning and research to validate conclusions, address bias, and ensure ethical standards, while user feedback enhances creativity and intellect.

AI guidelines are designed to guide authors in addressing ethical and technical aspects of AI usage. More details about AI Guidelines are available here.

Digital Archiving

Digital archiving safeguards digital content from technological changes and data loss, ensuring journal longevity and integrity through Portico and CLOCKSS services, ensuring accessibility for researchers and educators. Articles in our journal are securely preserved and remain accessible to researchers, educators, and the public, today and in the future.

Advertising Policy

The Journal retains the discretion to decline any advertisement that does not meet the Journal's advertising policy.

1. Advertisements will not be accepted if they are indecent, offensive, or discriminatory based on personal, racial, ethnic, sexual orientation, or religious grounds, whether in text or artwork.

2. The Journal will not accept advertisements for products or services known to be harmful to health, such as tobacco and alcohol.

3. Product advertorials will not allow any treatment-specific or drug-specific campaigns to target specific articles related to the advertised products.

Advertisements on the Journal's website do not imply endorsement or approval from the publisher, and editorial decisions are not influenced by these advertisements.

Ahead of Print Policy

Articles published online under the "Ahead of Print" model are considered published and can be cited and quoted using DOI, This policy ensures that important research is available to the scientific community as quickly as possible, without the delay of waiting for a print issue. These articles are officially published and should be cited using their permanent Digital Object Identifier (DOI). Once an article is published "Ahead of Print," it is considered the final Version of Record. Therefore, no changes can be made to the content. Any necessary corrections to the scientific record will be made through formal notices, such as an Erratum or Corrigendum, in accordance with publication ethics guidelines.

Revenue Sources

This is a self-financed open access journal, which is published in both online and print versions. Article publication charges levied on authors are the only source of income used to maintain administrative and printing costs. Also, a small portion of revenue comes from advertisements and subscriptions. The APC is based on an adjusted scale, providing reduced rates for low- and middle-income countries. Operating expenses, including the cost of web presence, print versions, pre-press preparations, and staff salaries, are supported by the above-mentioned resources. Please visit for APC details .

About Publisher

IP Innovative Publication Private Limited is a well-established publisher headquartered in New Delhi, India. The publisher specializes in medical, dental, nursing, and pharmacy subjects and has more than 400+ books and 50 journals in its portfolio. Founded in 2010, it has become a well-respected medical publisher in India that fully supports various open-access models through its robust peer-review management system. Researchers, students, scholars, clinicians, and other healthcare professionals access the publisher's journals from around the globe to learn about the latest discoveries and improve patient care. More information about the publisher is available here.